BN82002 hydrochloride is primarily utilized in the field of medical research, particularly in the study of neurological disorders. It is known for its potential as a pharmacological tool in investigating the mechanisms of neurodegenerative diseases. The compound has shown promise in modulating specific pathways that are implicated in the progression of conditions such as Alzheimer's disease and Parkinson's disease. Researchers are exploring its efficacy in protecting neuronal cells from damage and improving cognitive functions in preclinical models. Additionally, BN82002 hydrochloride is being studied for its potential therapeutic applications in reducing neuroinflammation and oxidative stress, which are key factors in the pathology of various brain disorders. Its role in enhancing synaptic plasticity and memory retention is also under investigation, making it a valuable candidate for developing novel treatments for cognitive impairments.